News | March 20, 2026
LANXESS marks 40 yrs of animal disease defense 'Virkon S'
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
A disinfectant credited with helping contain some of the world’s most dangerous livestock diseases is marking a major milestone
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
The Taipei facility boasts 10 GMP API production lines, with a total reactor volume exceeding 350,000 liters
The trial will enroll up to 42 patients in Finland across four cohorts
Lilly has long voiced concerns over mass-compounded knockoffs of its tirzepatide medicines, Mounjaro and Zepbound
One task, one interaction, one pair, experts advocate
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
Subscribe To Our Newsletter & Stay Updated
